AGIOS PHARMACEUTICALS INC (AGIO) Forecast, Price Target & Analyst Ratings

NASDAQ:AGIO • US00847X1046

Current stock price

28.33 USD
+3.53 (+14.23%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AGIOS PHARMACEUTICALS INC (AGIO).

Forecast Snapshot

Consensus Price Target

Price Target
$43.28
+ 52.76% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q2 / 2026
EPS Estimate
-$1.74
Revenue Estimate
19.619M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.25%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$43.28
Upside
+ 52.76%
From current price of $28.33 to mean target of $43.28, Based on 16 analyst forecasts
Low
$28.28
Median
$44.88
High
$68.25

Price Target Revisions

1 Month
6.07%
3 Months
10.41%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for AGIO. The average price target is 43.28 USD. This implies a price increase of 52.76% is expected in the next year compared to the current price of 28.33.
The average price target has been revised upward by 10.41% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AGIO Current Analyst RatingAGIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

AGIO Historical Analyst RatingsAGIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
81.25%
AGIO was analyzed by 16 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about AGIO.
In the previous month the buy percentage consensus was at a similar level.
AGIO was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-21B of A SecuritiesMaintains Buy -> Buy
2026-04-20HC Wainwright & Co.Maintains Buy -> Buy
2026-04-06JP MorganMaintains Neutral -> Neutral
2026-04-01Goldman SachsMaintains Neutral -> Neutral
2026-03-05CitigroupMaintains Buy -> Buy
2026-02-12HC Wainwright & Co.Maintains Buy -> Buy
2026-01-06JP MorganMaintains Neutral -> Neutral
2025-12-26Leerink PartnersMaintains Outperform -> Outperform
2025-12-24Truist SecuritiesMaintains Buy -> Buy
2025-12-24B of A SecuritiesMaintains Buy -> Buy
2025-12-24HC Wainwright & Co.Maintains Buy -> Buy
2025-11-26CitigroupInitiate Buy
2025-11-24Truist SecuritiesInitiate Buy
2025-11-21JP MorganMaintains Neutral -> Neutral
2025-11-20Leerink PartnersUpgrade Market Perform -> Outperform
2025-11-20RBC CapitalDowngrade Outperform -> Sector Perform
2025-11-20Goldman SachsMaintains Neutral -> Neutral
2025-11-20B of A SecuritiesMaintains Buy -> Buy
2025-11-20HC Wainwright & Co.Maintains Buy -> Buy
2025-09-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-28ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-07-22B of A SecuritiesMaintains Buy -> Buy
2025-05-02ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-02-24HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-18Cantor FitzgeraldReiterate Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q2 / 2026
EPS Estimate
-$1.74
Revenue Estimate
19.619M
Revenue Q2Q
57.52%
EPS Q2Q
9.64%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
2.61%
Revenue (3 Months)
-10.36%
EPS (1 Month)
0.28%
EPS (3 Months)
1.25%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 10.36% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
AGIO revenue by date.AGIO revenue by date.
26.823M
88.36%		36.498M
36.07%		54.028M
48.03%		95.494M
76.75%		258.53M
170.73%		403.07M
55.91%		498.51M
23.68%		651.87M
30.76%		731.02M
12.14%		855.54M
17.03%		986.81M
15.34%
EBITDA
YoY % growth
AGIO ebitda by date.AGIO ebitda by date.
-384.864M
-1.15%		-420.084M
-9.15%		-466.955M
-11.16%		-453.342M
2.92%		-361.214M
20.32%		-218.343M
39.55%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
AGIO ebit by date.AGIO ebit by date.
-391.487M
-0.63%		-425.737M
-8.75%		-472.132M
-10.90%		-452.938M
4.07%		-361.438M
20.20%		-236.458M
34.58%		-191.659M
18.95%		-40.762M
78.73%		115.71M
383.87%		256.87M
121.99%		393.65M
53.25%
Operating Margin
AGIO operating margin by date.AGIO operating margin by date.
-1,459.52%-1,166.47%-873.87%-474.31%-139.81%-58.66%-38.45%-6.25%15.83%30.02%39.89%
EPS
YoY % growth
AGIO eps by date.AGIO eps by date.
-6.34
-49.53%		-7.00
-10.35%		-7.12
-1.77%		-6.75
5.20%		-5.27
21.96%		-3.49
33.66%		-2.45
30.00%		-0.17
92.91%		-0.01
92.18%		1.30
9,699.25%		2.72
108.61%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.74
9.64%		-1.61
9.75%		-1.51
19.03%
Revenue
Q2Q % growth		19.619M
57.52%		26.536M
106.02%		34.792M
73.96%
EBITDA
Q2Q % growth		-119.261M
4.22%		-109.611M
2.96%		-104.755M
10.01%
EBIT
Q2Q % growth		-115.803M
8.86%		-109.008M
6.73%		-104.664M
13.91%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AGIO Yearly Revenue VS EstimatesAGIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
AGIO Yearly EPS VS EstimatesAGIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
14.71%
EPS Next 5 Year
14.59%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
105.19%
Revenue Next 5 Year
69.45%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
15.79%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AGIOS PHARMACEUTICALS INC / AGIO Forecast FAQ

What is the price target for AGIO stock?

16 analysts have analysed AGIO and the average price target is 43.28 USD. This implies a price increase of 52.76% is expected in the next year compared to the current price of 28.33.

What are the consensus estimates for AGIOS PHARMACEUTICALS INC (AGIO) next earnings?

The consensus EPS estimate for the next earnings of AGIOS PHARMACEUTICALS INC (AGIO) is -1.74 USD and the consensus revenue estimate is 19.62M USD.

Can you provide the expected long term growth rate for AGIOS PHARMACEUTICALS INC stock?

The expected long term growth rate for AGIOS PHARMACEUTICALS INC (AGIO) is 105.19%.